Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children.
about
Glycosylation, hypogammaglobulinemia, and resistance to viral infectionsImpaired generation of hepatitis B virus-specific memory B cells in HIV infected individuals following vaccinationPhase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescents.Guidance on vaccination of HIV-infected children in Europe.Safety and immunogenicity of quadrivalent meningococcal conjugate vaccine in 2- to 10-year-old human immunodeficiency virus-infected children.Immunogenicity and safety of meningococcal C conjugate vaccine in children and adolescents infected and uninfected with HIV in Rio de Janeiro, Brazil.Suboptimal immune reconstitution in vertically HIV infected children: a view on how HIV replication and timing of HAART initiation can impact on T and B-cell compartmentImmunogenicity and safety of 1 vs 2 doses of quadrivalent meningococcal conjugate vaccine in youth infected with human immunodeficiency virus.Pediatric HIV infection: immune and viral evaluation.Antiretroviral therapy for children: challenges and opportunities.Immunogenicity and safety of the human papillomavirus 6, 11, 16, 18 vaccine in HIV-infected young womenVaccines to prevent pneumonia and improve child survival.Safety of live, attenuated oral vaccines in HIV-infected Zambian adults: oral vaccines in HIVPathogenic mechanisms of B-lymphocyte dysfunction in HIV diseaseTiming of HAART defines the integrity of memory B cells and the longevity of humoral responses in HIV-1 vertically-infected children.Decreased mutation frequencies among immunoglobulin G variable region genes during viremic HIV-1 infection.Management of community-acquired pneumonia in HIV-infected children.Contribution of Maternal Immunity to Decreased Rotavirus Vaccine Performance in Low- and Middle-Income Countries.Immune reconstitution and vaccination outcome in HIV-1 infected children: present knowledge and future directions.Integrating HIV testing into immunological studies of non-HIV-related diseases.Immunogenicity of a Booster Dose of Quadrivalent Meningococcal Conjugate Vaccine in Previously Immunized HIV-Infected Children and Youth.Assessment of the HBV vaccine response in a group of HIV-infected children in Morocco.CPG 7909 adjuvant plus hepatitis B virus vaccination in HIV-infected adults achieves long-term seroprotection for up to 5 years.Effect of innate antiviral glycoproteins in breast milk on seroconversion to rotavirus vaccine (Rotarix) in children in Lusaka, Zambia.
P2860
Q33789632-F19DBF08-543E-4D17-BEFB-E1157120261DQ33820427-DA6FF2E4-1728-4442-B3C6-8895A6EABD79Q33844571-0E0B9EA4-426D-49EB-B373-0AC47DFA3DC8Q34251138-3F22A6DA-351C-43C1-9A6E-FC41214A1F15Q35655927-C3C98258-5B91-47F4-978C-15D745698D79Q35680467-55E46810-6A11-4252-8F95-B624C2F3D12DQ35895763-1E59C05F-DC41-40D6-AE71-D9BB867B5A25Q36210265-A3751312-1196-4FD5-BFF8-6E9AA1C889D6Q36793648-04025ABF-8C0D-4F61-9190-B26F11850224Q36806770-B9437DC1-5469-401F-B6FE-12F20C45DA75Q37084984-E41E0C96-A3E4-4A21-98F0-F04D0E51F6D1Q37108802-0E246B8D-CCF8-44A8-AE63-47531437033DQ37187396-AF44FF38-8499-4539-AABA-0F2809836DC6Q37189179-23313CFC-2761-4CDB-B67D-36C3D240EA22Q37194666-25C4C5C0-1160-4E7E-972E-C2792D57E2D6Q37444828-6EAFE7A9-4B92-4A41-93B1-B587D279674DQ37463218-2727CAA4-18E7-43A5-8B2C-436EBE354E05Q37563622-E0C37FC1-F0A0-471C-94E5-DFC93F0A953AQ38036063-C7971274-D903-467B-96AA-7406BAED9D91Q39494516-4FCE90E2-3E14-4B14-8765-A6E1F6DF778BQ40275424-249C9689-2856-45BC-B69B-66D8C9E8E943Q41927775-FC420ED1-8816-4E85-B8AF-16A40AE431F8Q45395440-4E150FFB-2D11-41F7-8C22-8FCED16B56FEQ47546357-186E1547-CB0D-4FB5-878A-7FAD9AD7DC90
P2860
Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children.
@ast
Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children.
@en
type
label
Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children.
@ast
Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children.
@en
prefLabel
Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children.
@ast
Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children.
@en
P2093
P1476
Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children.
@en
P2093
P304
P356
10.1016/S1473-3099(04)01106-5
P577
2004-08-01T00:00:00Z